35Patient contribution for chemotherapy pharmaceutical benefits mentioned in Schedule 4

35 Patient contribution for chemotherapy pharmaceutical benefits mentioned in Schedule 4

(1) This section applies if the chemotherapy pharmaceutical benefit supplied by an approved hospital authority to an eligible patient is:

(a) a listed drug mentioned in the column in Schedule 4 headed ‘Listed Drug’; and

(b) in the form mentioned in the column in Schedule 4 headed ‘Form’ for the listed drug mentioned in paragraph (a); and

(c) administered in a manner mentioned in the column in Schedule 4 headed ‘Manner of ‘Manner of Administration’ for the listed drug mentioned in paragraph (a); and

(d) marketed under the brand mentioned in the column in Schedule 4 headed ‘Brand’ for the listed drug mentioned in paragraph (a).

(2) The approved hospital authority may charge the eligible patient:

(a) an amount not exceeding the amount that the patient could have been required to pay in accordance with subsection 87(2) of the Act if the patient had obtained the chemotherapy pharmaceutical benefit from an approved pharmacist; and

(b) an amount not exceeding the amount mentioned in subsection 37 (1).